pegvisomant
Drug Details
- Generic Name
- pegvisomant
- Brand Names
- SOMAVERT
- Application Number
- BLA021106
- Sponsor
- Pharmacia & Upjohn Company LLC
- NDC Codes
- 11
- Dosage Forms
- KIT, INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION, PASTE
- Routes
- N/A
- Active Ingredients
- PEGVISOMANT
Indications and Usage
1 INDICATIONS AND USAGE SOMAVERT is indicated for the treatment of acromegaly in patients who have had an inadequate response to surgery or radiation therapy, or for whom these therapies are not appropriate. The goal of treatment is to normalize serum insulin-like growth factor-1 (IGF-1) levels. SOMAVERT is a growth hormone receptor antagonist indicated for the treatment of acromegaly in patients who have had an inadequate response to surgery or radiation therapy, or for whom these therapies are not appropriate. The goal of treatment is to normalize serum insulin-like growth factor-1 (IGF-1) levels. ( 1 )